FES cycling

DEVICE6 trials

Conditions

Critically Ill Patients Under Mechanical VentilationDisability PhysicalInflammatory MyelopathiesMuscle WeaknessParaplegiaSedated PatientsSpinal Cord InjurySpinal Cord Injury, Acute

Phase 2

Study on Functional Electrical Stimulation (FES) Cycling Following Spinal Cord Injury

TerminatedNCT01217047

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Spinal Cord Injury

Start: 2010-10-31End: 2013-08-31Updated: 2021-01-27

Phase 3

Haemodynamic and Metabolism Response During Early Rehabilitation in Sedated Patients

CompletedNCT02920684

University Hospital, RouenCritically Ill Patients Under Mechanical Ventilation, Sedated Patients

Start: 2016-12-31End: 2017-08-31Updated: 2017-08-02

Unknown Phase

CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies

TerminatedNCT01440452

Johns Hopkins UniversityInflammatory Myelopathies

Start: 2010-11-30End: 2019-07-31Updated: 2020-07-17

Safety Evaluation of Functional Electrical Stimulation (FES) Cycling in Intensive Care Unit Patients

CompletedNCT03526211

Centre Hospitalier Universitaire de Saint EtienneMuscle Weakness

Start: 2018-07-24End: 2019-06-18Updated: 2019-07-15

Motor-assisted Cycling and FES Cycling for Postprandial Glucose in Diabetic Patients With ADL Disability

CompletedNCT03994289

Arizona State UniversityDisability Physical, Type2 Diabetes

Start: 2019-02-20End: 2019-11-15Updated: 2019-11-15

Functional Electrical Stimulation Cycling in SCI

NCT04064385

Glasgow Caledonian UniversityParaplegia, Spinal Cord Injury, Acute, Tetraplegia

Start: 2019-06-01End: 2020-07-31Target: 12Updated: 2019-08-21

Related Papers

Comparison of exercise intensity during four early rehabilitation techniques in sedated and ventilated patients in ICU: a randomised cross-over trial

Critical Care2018-04-2779 citations

Effects of different early rehabilitation techniques on haemodynamic and metabolic parameters in sedated patients: protocol for a randomised, single-bind, cross-over trial